XML 12 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Earnings (unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Income Statement [Abstract]        
Net Sales $ 1,954.4 $ 1,934.0 $ 3,931.7 $ 3,838.0
Cost of products sold, excluding intangible asset amortization 527.7 640.1 1,040.6 1,280.7
Intangible asset amortization 147.7 133.8 299.7 260.4
Research and development 90.1 88.6 181.2 174.3
Selling, general and administrative 748.0 732.0 1,508.8 1,448.9
Special items (Note 2) 158.6 137.9 268.7 226.6
Operating expenses 1,672.1 1,732.4 3,299.0 3,390.9
Operating Profit 282.3 201.6 632.7 447.1
Other expense, net (3.9) (3.8) (6.7) (7.6)
Interest income 0.3 0.8 0.8 2.1
Interest expense (82.3) (88.1) (165.2) (176.3)
Earnings before income taxes 196.4 110.5 461.6 265.3
Provision (benefit) for income taxes 12.3 142.2 (21.8) 188.3
Net Earnings (Loss) 184.1 (31.7) 483.4 77.0
Less: Net loss attributable to noncontrolling interest (0.1) (0.4) (0.2) (0.5)
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc. $ 184.2 $ (31.3) $ 483.6 $ 77.5
Earnings (Loss) Per Common Share        
Basic $ 0.91 $ (0.16) $ 2.40 $ 0.39
Diluted $ 0.90 $ (0.16) $ 2.38 $ 0.38
Weighted Average Common Shares Outstanding        
Basic 201.8 199.4 201.4 199.8
Diluted 203.7 199.4 203.4 202.1
Cash Dividends Declared Per Common Share $ 0.24 $ 0.24 $ 0.48 $ 0.48